Maya Hacini Selected Research

Maya Hacini Research Topics

2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 04/2020 - 01/2017
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2019 - 01/2017
2	Iron Overload 05/2018 - 12/2009
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 05/2018 - 06/2010
2	Neutropenia 01/2017 - 05/2013
2	Hematologic Neoplasms (Hematological Malignancy) 01/2017 - 05/2016
1	Neoplasms (Cancer) 01/2017
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2017
1	Hemophilia A (Haemophilia) 05/2016
1	Breast Neoplasms (Breast Cancer) 12/2015
1	Multiple Myeloma 10/2013
1	Venous Thromboembolism 10/2013
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 05/2013
1	Extranodal NK-T-Cell Lymphoma 06/2012

6	Rituximab (Mabthera)FDA Link 04/2020 - 05/2013
2	IronIBA 05/2018 - 12/2009
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2017 - 05/2013
2	Prednisone (Sone)FDA LinkGeneric 01/2017 - 05/2013
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017 - 05/2013
2	Vincristine (Oncovin)FDA LinkGeneric 01/2017 - 05/2013
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2015 - 05/2013
1	Deferasirox FDA Link 05/2018
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Biosimilar PharmaceuticalsIBA 01/2017
1	Filgrastim (Neupogen)FDA Link 01/2017
1	Hemostatics (Antihemorrhagics)IBA 05/2016
1	Azacitidine (5 Azacytidine)FDA Link 05/2016
1	Factor VIII (Coagulation Factor VIII)IBA 05/2016
1	Methylprednisolone FDA LinkGeneric 05/2016
1	Factor VIIa (Activated Factor VII)IBA 05/2016
1	Immunomodulating AgentsIBA 10/2013
1	factor AIBA 05/2013
1	Chelating AgentsIBA 12/2009
1	Deferoxamine (Desferal)FDA LinkGeneric 12/2009

4	Drug Therapy (Chemotherapy) 04/2020 - 06/2012
1	Stem Cell Transplantation 04/2020
1	Chelation Therapy (Therapy, Chelation) 05/2018
1	Therapeutics 05/2016
1	VAP-cyclo protocol 05/2013
1	Erythrocyte Transfusion 06/2010
1	Blood Transfusion (Blood Transfusions) 12/2009
1	Subcutaneous Infusions 12/2009